Phazemos Helped Find the Right Investment Partner

Navigating the complex world of investment funding can be challenging, especially for those in the biotech and healthcare sectors. At Phazemos, we recognize these challenges and have developed a strategic approach to help our members secure the investment they need to propel their innovations forward. Here's how our network played a pivotal role in finding the right investment partner for one of our members.

The Challenge

A promising biotech company reached out to Phazemos with a goal to raise a $3 million seed round. They needed a partner who could not only provide the necessary capital but also add value through industry expertise and strategic connections. Our task was clear, and we were ready to leverage our flexible Match Program to make it happen.

Our Approach

Our Match Program is designed with flexibility in mind, allowing our members to raise funds independently while tapping into our extensive network and resources where needed. This non-exclusive model ensures that our members retain control over their fundraising processes, leveraging our support as a strategic layer rather than a restrictive framework.

With this in mind, Phazemos went to work, connecting with potential investors who aligned with the biotech company's vision and goals. Our focus was on creating a collaborative environment where both the member and the investors felt supported and aligned.

Results Achieved

Within six months, Phazemos successfully secured $1.1 million of the seed round funding, while the company independently raised the remaining $1.9 million. This accomplishment underscored the efficacy of our partnership-centric approach, allowing our members to maintain autonomy and flexibility in their fundraising efforts.

"Phazemos has been helping us raise capital for a number of months, and we are pleased that they have secured a term sheet with one investor and continue to be active in securing additional investment."
-Non-executive Director, Biotech Company

Looking Ahead

With the seed round successfully completed, our member is now gearing up for a $15 million Series A round. Phazemos remains committed to supporting them through this next phase of growth. By leveraging our network and expertise, we aim to facilitate their continued success and expansion within the biotech industry.

Conclusion

At Phazemos, our mission is to empower biotech companies by connecting them with the right investment partners—without imposing restrictive agreements. Our collaborative approach has proven effective in achieving funding goals while preserving our members' independence and flexibility. We look forward to continuing to support innovative companies in their journeys toward success.

For biotech providers and investors looking for strategic partnerships, Phazemos offers a proven and flexible model to meet your funding needs. Connect with us today to learn how we can help you achieve your financial goals.